91 related articles for article (PubMed ID: 7941780)
21. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity.
Unterwald EM; Cox BM; Kreek MJ; Cote TE; Izenwasser S
Synapse; 1993 Sep; 15(1):33-8. PubMed ID: 8310423
[TBL] [Abstract][Full Text] [Related]
22. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
23. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
25. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
Noel MB; Gratton A
Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972
[TBL] [Abstract][Full Text] [Related]
26. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
27. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
[TBL] [Abstract][Full Text] [Related]
28. Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes.
Bakshi VP; Kelley AE
J Pharmacol Exp Ther; 1993 Jun; 265(3):1253-60. PubMed ID: 8389860
[TBL] [Abstract][Full Text] [Related]
29. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouse.
Ukai M; Toyoshi T; Kameyama T
Brain Res; 1991 Aug; 557(1-2):77-82. PubMed ID: 1660758
[TBL] [Abstract][Full Text] [Related]
30. Naltrexone-sensitizing effects of centrally administered morphine and opioid peptides.
Adams JU; Holtzman SG
Eur J Pharmacol; 1991 Jan; 193(1):67-73. PubMed ID: 1675608
[TBL] [Abstract][Full Text] [Related]
31. Effects of intrahypothalamic administration of opioid peptides selective for mu-, kappa, and delta-receptors on different schedules of water intake in the rat.
Ukai M; Holtzman SG
Brain Res; 1988 Sep; 459(2):275-81. PubMed ID: 2902901
[TBL] [Abstract][Full Text] [Related]
32. Effects of centrally administered neuropeptides on discriminative stimulus properties of cocaine in the rat.
Ukai M; Mori E; Kameyama T
Pharmacol Biochem Behav; 1995 Aug; 51(4):705-8. PubMed ID: 7675847
[TBL] [Abstract][Full Text] [Related]
33. [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice.
Murray CW; Cowan A
Psychopharmacology (Berl); 1990; 102(3):425-6. PubMed ID: 2251341
[TBL] [Abstract][Full Text] [Related]
34. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
Ukai M; Holtzman SG
Psychopharmacology (Berl); 1988; 94(1):32-7. PubMed ID: 2894701
[TBL] [Abstract][Full Text] [Related]
35. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
Katoh A; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1990 May; 253(2):600-7. PubMed ID: 1971017
[TBL] [Abstract][Full Text] [Related]
36. Effects of mu and delta opioid receptor agonists and antagonists on absence epilepsy in WAG/Rij rats.
Lasoń W; Przewłocka B; Coenen A; Przewłocki R; Van Luijtelaar G
Neuropharmacology; 1994 Feb; 33(2):161-6. PubMed ID: 8035901
[TBL] [Abstract][Full Text] [Related]
37. The influence of opioid peptides on steroidogenesis in porcine granulosa cells.
Kaminski T; Siawrys C; Bogacka I; Okrasa S; Przala J
Reprod Domest Anim; 2004 Feb; 39(1):25-32. PubMed ID: 15129917
[TBL] [Abstract][Full Text] [Related]
38. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats.
Zhang M; Kelley AE
Psychopharmacology (Berl); 1997 Aug; 132(4):350-60. PubMed ID: 9298512
[TBL] [Abstract][Full Text] [Related]
39. mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.
Gunion MW; Rosenthal MJ; Morley JE; Miller S; Zib B; Butler B; Moore RD
Am J Physiol; 1991 Jul; 261(1 Pt 2):R70-81. PubMed ID: 1677542
[TBL] [Abstract][Full Text] [Related]
40. Dynorphin A(1-13) modulates apomorphine-induced behaviors using multidimensional behavioral analyses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Brain Res; 1989 Oct; 499(2):299-304. PubMed ID: 2572301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
